Navigation Links
SyntheMed Announces FDA Clearance of SinusShield(TM)
Date:11/19/2008

ISELIN, N.J., Nov. 19 /PRNewswire-FirstCall/ -- SyntheMed, Inc. (OTC Bulletin Board: SYMD) announced today that it has received FDA 510(k) clearance to market SinusShield(TM), a bioresorbable membrane intended to prevent post-operative adhesions in nasal and sinus surgical procedures. There are approximately two million nasal and sinus procedures performed annually in the United States.

Robert P. Hickey, SyntheMed's President & CEO stated, "SinusShield represents an example of our strategy to capitalize on our proprietary polymer film technology in new surgical applications both in the United States and international markets." The company is in discussion with prospective partners with the distribution infrastructure to service the office-based and hospital outpatient sites where these procedures are performed.

About SinusShield(TM)

SinusShield is a bioresorbable polymer membrane indicated for use in patients undergoing nasal and sinus surgical procedures as a space-occupying stent to separate and prevent adhesions between mucosal surfaces. During surgical procedures involving the sinuses and sinus passages, it is common for surgeons to place silastic tubes or sheets in the sinus passages to prevent blockage caused by adhesion formation; however, these materials must often be removed in a second procedure. SinusShield is intended to prevent blockage and then biodegrade thereby eliminating the second procedure.

About SyntheMed, Inc.

SyntheMed, Inc. is a biomaterials company engaged in the development and commercialization of anti-adhesion products and other surgical implants based on its proprietary bioresorbable polymer technology. The company is developing a portfolio of anti-adhesion products led by REPEL-CV(R) Adhesion Barrier, an anti-adhesion product intended for use in open heart surgical procedures. REPEL-CV is currently marketed internationally and is
'/>"/>

SOURCE SyntheMed, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. SyntheMed to Host Symposium on Adhesions in Cardiac Surgery
2. SyntheMed to Present at the Acumen BioFin Conference
3. SyntheMed Files Universal Shelf Registration
4. SyntheMed to Present at Canaccord Adams Small-Cap Orthopedics Conference
5. SyntheMed To Present at the AdvaMed 2008 MedTech Conference
6. SyntheMed Completes $4.0 Million Equity Placement
7. SyntheMed Announces New Management Appointments
8. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
9. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
10. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
11. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2009)...tional sustained follicle stimulant achieves simil...a given over a one week period in Phase III Study ... Schering-Plough Corp., (NYSE: SGP ) today annou...ial demonstrating that a single injection of corif...ollicle stimulants, achieved similar efficacy to r...
(Date:7/1/2009)...y 1 Human Genome Scienc... expects to have top-line results available on Mon...tal Phase 3 clinical trials of BENLYSTA(TM) (belim...erythematosus (SLE). , , (Logo: http://www... , Senior management will host a conference call...
(Date:6/30/2009)...DUSTRY, Calif. and HONG KONG, June 30 /PRNewswire-...ets: EFTB), announced today that Excalibur,s Ocean...wan Strait passenger voyage which has been highlig...ites, including the Taiwan Sun, and the Qatar Trib...y launched a cruise service with China on Sunday, ...
(Date:6/30/2009)...ings Conference Call Tuesday, August 4, 2009, 5:00...RNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: ...s conference call covering second quarter 2009 res... , , August 4, 2009 Schedule , , 4:10... PRNewswire, 4:50 p.m. EDT To participate in...
Breaking Biology Technology:Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 2Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 3Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 4Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 5Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 6Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 7Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 8Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 9Human Genome Sciences to Host July 20 Conference Call to Discuss Top-Line Phase 3 Results for Benlysta(TM) (Formerly Lymphostat-B(R)) in Systemic Lupus Erythematosus 2Excalibur International Marine (49% Owned by EFT BioTech Holdings) Completes Inaugural Passenger Crossing of Taiwan Strait 2Excalibur International Marine (49% Owned by EFT BioTech Holdings) Completes Inaugural Passenger Crossing of Taiwan Strait 3
...cAllister, Nina Tang, Lawrence C. Katz, and Donald...biology, Box 3209, Duke University Medical Center,... , Introduction , The introduc... interest , remains a rate-limiting step ... especially neurobiology. Many different meth...
... Introduction , The DC Protein Assay...are required for cell lysis of many cell samples p... The following protocol,can be used for tissue c... acid, or acetone treatment; or any other samples ... for solubilization. , , P...
... The following protocol is an adaptation for prot...ents such as DTT (dithiothreitol),and BME (2-mer...neutralize up to 50 mM BME or 5 mM DTT., ...ein Assay, Bio-Rad Laboratories catalog numbers 50...oacetamide, DTT, 1 g, Bio-Rad Laboratorie...
...ed by Alan T. Bakalinsky Department of Food Scienc...ty, Corvallis, OR 97331-6602, , Abstr...ins of Saccharomyces cerevisiae were , co.... Qualitative analysis , supported previo...re aneuploid , and two diploid. Obstacles...
Other Biology Technology:Biolistic Transfection of Organotypic Brain Slices 2Biolistic Transfection of Organotypic Brain Slices 3Biolistic Transfection of Organotypic Brain Slices 4Biolistic Transfection of Organotypic Brain Slices 5Biolistic Transfection of Organotypic Brain Slices 6Biolistic Transfection of Organotypic Brain Slices 7Biolistic Transfection of Organotypic Brain Slices 8Biolistic Transfection of Organotypic Brain Slices 9Biolistic Transfection of Organotypic Brain Slices 10Total Cellular Protein Determination Using the DC Protein Assay 2Modification of Bio-Rad DC Protein Assay for Use With Thiols 2Electrophoretic Karyotypes of Wine Strains of Saccharomyces cerevisiae 2Electrophoretic Karyotypes of Wine Strains of Saccharomyces cerevisiae 3Electrophoretic Karyotypes of Wine Strains of Saccharomyces cerevisiae 4Electrophoretic Karyotypes of Wine Strains of Saccharomyces cerevisiae 5Electrophoretic Karyotypes of Wine Strains of Saccharomyces cerevisiae 6
(Date:7/1/2009)...oday announced that Axel Ullrich, Ph.D., director ...Planck Institute of Biochemistry in Germany, whose...cluding Herceptin (trastuzumab) , is the winner of...search. An independent committee of world-renowne...r 8 will receive a $100,000 prize during a ceremon...
(Date:7/1/2009)...the centromere, a key cellular structure in poweri...rate cell division, has just earned him a paper in...allation grant, of 50,000 euro per year, for a max...ifornia to the Instituto Gulbenkian de Cincia (IGC...echanisms group. The Nature Cell Biology paper, ...
(Date:7/1/2009)...m across the United States and Russia are departin...ian Arctic. The program, known as The Polaris Proj... and education, and informing the public about the...s, an associate scientist at the Woods Hole Resear...s, "The Arctic is central to the global climate ch...
(Date:7/1/2009)...ggesting that damage to nerve cells in people with... natural mechanism for repair of the nerve coating...shed today, July 1, 2009, in the print edition of ...ts at the University of California, San Francisco ...by co-senior investigator David Rowitch, MD, PhD, ...
Breaking Biology News(10 mins):Axel Ullrich named winner of 2009 Dr. Paul Janssen Award for Biomedical Research 2Double success for Instituto Gulbenkian de Ciencia scientists working on chromosome segregation 2International team of students and scientists on month-long field course in Siberian Arctic 2International team of students and scientists on month-long field course in Siberian Arctic 3MS study offers theory for why repair of brain's wiring fails 2MS study offers theory for why repair of brain's wiring fails 3Hospira to Present at the 2008 Annual Credit Suisse Health Care Conference on November 12 28719 1Response rates to antidepressants differ among English and Spanish speaking Hispanics 28717 1Response rates to antidepressants differ among English and Spanish speaking Hispanics 28717 2Hydrogen tank lighter than battery 5722 1Hydrogen tank lighter than battery 5722 2Coral reefs found growing in cold deep ocean 5720 1Coral reefs found growing in cold deep ocean 5720 2
...ial demonstrate that high doses of an experimental...sponses in healthy adults. , Approximately half o...ooster dose of the highest dosage of the vaccine t...ighting antibodies that current tests predict woul...Allergy and Infectious Diseases (NIAID), part of t...
... real estate may be its most important feature to ...he University of California, San Diego (UCSD) and ...location of genes and other features distributed a...isms also is fundamentally important to how microb...online in PLoS Computational Biology, the research...
...e first large-scale analysis of interactions betwe...ing new genes involved in genetic diseases, accord...ute of Bioinformatics (IOB) in Bangalore. , The fi...tics, were made using a database of more than 25,0...pkins-IOB team. The result is believed to be the ...
...d newlywed in San Francisco, is just one of the ma...large clinical trial in India. , The trial is stu...Inhibition of Sperm Under Guidance): a reversible,...e years of protection after a 10-15 minute procedu...in enrolling additional study volunteers, after a ...
Other Biology News:H5N1 avian flu virus vaccine induces immune responses in healthy adults 2H5N1 avian flu virus vaccine induces immune responses in healthy adults 3Patterns in genome organization may partially explain how microbial cells work 2Patterns in genome organization may partially explain how microbial cells work 3Largest study of human 'interactome' reveals a novel way 2Largest study of human 'interactome' reveals a novel way 3New male contraceptive clears hurdle 2New male contraceptive clears hurdle 3
...ials necessary for the isolation and preparation o...is. Kit Components: Erythrocyte Lysis Buffer ...of buffered ammonium chloride. (NH 4 Cl) Fixation...taining 220 mL of PBS, formalin, sucrose and 0.5% ...
The CultureWell cell culture systems provide an integrated set-up for preparing cultured cells for staining and imaging. Each system uses medical-grade silicone gaskets preassembled with standard opt
ANTI NO-TRYPTOPHAN CONJUGATE
The Zero Background/Kan Cloning Kit includes the pZErO-2 vector with kanamycin resistance for selection in E. coli. The pZErO-2 vector utilizes positive selection to eliminate high background. The ki
Biology Products: